Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. drugs
5 results
Albumin (human) (albumin human)
(Albumin Human)Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
Usage: Albumin (Human) 5% is indicated for the emergency treatment of hypovolemia, particularly when hydration is inadequate, and for critically ill patients with hypoalbuminemia. It also aids in maintaining cardiovascular function after paracentesis due to cirrhotic ascites.
Albumin (human) (albumin human)
(Albumin Human)Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
Usage: ALBUMIN (HUMAN) 20% is indicated for treating hypovolemia, hypoalbuminemia in critically ill patients, preventing central volume depletion after paracentesis, managing severe ovarian hyperstimulation syndrome, aiding fluid management in adult respiratory distress syndrome, treating edema in acute nephrosis, and addressing hyperbilirubinemia in hemolytic disease of the newborn.
Albumin (human) (albumin human)
(Albumin Human)Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
Usage: ALBUMIN (HUMAN) 25% is indicated for treating hypovolemia, hypoalbuminemia in critically ill or active bleeding patients, maintaining cardiovascular function post-paracentesis for cirrhotic ascites, managing severe ovarian hyperstimulation syndrome, adjunct treatment for ARDS and acute nephrosis, and treating hyperbilirubinemia in hemolytic disease of the newborn.
Octagam immune globulin (human) (immune globulin)
(Immune Globulin)Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
Usage: Octagam is indicated for the treatment of primary humoral immunodeficiency diseases, including congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Wilate - von willebrand factor/coagulation factor viii complex (human) (von willebrand factor/coagulation factor viii complex (human))
(von Willebrand Factor/Coagulation Factor VIII Complex (Human))Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
Usage: Wilate is indicated for treating spontaneous and trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) and in mild or moderate VWD cases when desmopressin is ineffective or contraindicated. It is not for surgical bleeding prevention or for Hemophilia A. Prophylactic use has not been studied.